Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | fms-related tyrosine kinase 3 | Starlite/ChEMBL | References |
Homo sapiens | platelet-derived growth factor receptor, beta polypeptide | Starlite/ChEMBL | References |
Homo sapiens | discoidin domain receptor tyrosine kinase 2 | Starlite/ChEMBL | References |
Homo sapiens | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Starlite/ChEMBL | References |
Homo sapiens | platelet-derived growth factor receptor, alpha polypeptide | Starlite/ChEMBL | References |
Homo sapiens | ABL proto-oncogene 1, non-receptor tyrosine kinase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | vesicular amine transporter | 0.0049 | 0.0118 | 0.0118 |
Loa Loa (eye worm) | STE/STE7/MEK7 protein kinase | 0.2784 | 1 | 1 |
Echinococcus multilocularis | neuroglian | 0.0056 | 0.0146 | 0.0146 |
Echinococcus multilocularis | tyrosine protein kinase transmembrane receptor | 0.0016 | 0.0002 | 0.0002 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.0016 | 0.0002 | 0.0002 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.0131 | 0.0131 |
Schistosoma mansoni | protein kinase | 0.002 | 0.0014 | 0.0014 |
Echinococcus multilocularis | dual specificity testis specific protein kinase | 0.002 | 0.0014 | 0.0014 |
Trypanosoma brucei | STE/STE11 serine/threonine-protein kinase, putative | 0.002 | 0.0014 | 0.5 |
Schistosoma mansoni | titin | 0.0019 | 0.0009 | 0.0009 |
Echinococcus multilocularis | roundabout 2 | 0.006 | 0.0159 | 0.0159 |
Echinococcus granulosus | tyrosine protein kinase transmembrane receptor | 0.0016 | 0.0002 | 0.0002 |
Echinococcus granulosus | neuroglian | 0.0056 | 0.0146 | 0.0146 |
Loa Loa (eye worm) | hypothetical protein | 0.0104 | 0.0318 | 0.0318 |
Echinococcus granulosus | dual specificity mitogen activated protein | 0.2784 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0118 | 0.0118 |
Loa Loa (eye worm) | CAMK protein kinase | 0.0019 | 0.0009 | 0.0009 |
Echinococcus multilocularis | dual specificity mitogen activated protein | 0.2784 | 1 | 1 |
Echinococcus granulosus | Immunoglobulin | 0.0049 | 0.0118 | 0.0118 |
Echinococcus multilocularis | tyrosine protein kinase ABL1 | 0.0262 | 0.0887 | 0.0887 |
Loa Loa (eye worm) | STE/STE7/MEK7 protein kinase | 0.2784 | 1 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.002 | 0.0015 | 0.0015 |
Echinococcus granulosus | dual specificity testis-specific protein kinase | 0.002 | 0.0014 | 0.0014 |
Echinococcus granulosus | tyrosine protein kinase ABL1 | 0.0262 | 0.0887 | 0.0887 |
Onchocerca volvulus | Kinase homolog | 0.019 | 0.0627 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0118 | 0.0118 |
Echinococcus multilocularis | dual specificity mitogen activated protein | 0.019 | 0.0627 | 0.0627 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0061 | 0.0163 | 0.0163 |
Brugia malayi | Tyrosine-protein kinase abl-1 | 0.0154 | 0.0498 | 0.0498 |
Echinococcus granulosus | defective proboscis extension response | 0.0049 | 0.0118 | 0.0118 |
Loa Loa (eye worm) | TK/ABL protein kinase | 0.0262 | 0.0887 | 0.0887 |
Loa Loa (eye worm) | TK/DDR protein kinase | 0.0102 | 0.0309 | 0.0309 |
Schistosoma mansoni | defective proboscis extension response (dpr)-related | 0.0049 | 0.0118 | 0.0118 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0019 | 0.0009 | 0.0009 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0159 | 0.0159 |
Echinococcus multilocularis | basement membrane specific heparan sulfate | 0.0049 | 0.0118 | 0.0118 |
Schistosoma mansoni | protein kinase | 0.002 | 0.0014 | 0.0014 |
Echinococcus multilocularis | Immunoglobulin | 0.0049 | 0.0118 | 0.0118 |
Echinococcus multilocularis | tyrosine protein kinase Abl | 0.0111 | 0.0344 | 0.0344 |
Entamoeba histolytica | protein kinase domain containing protein | 0.002 | 0.0014 | 0.5 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0016 | 0.0002 | 0.0002 |
Echinococcus multilocularis | Immunoglobulin | 0.0049 | 0.0118 | 0.0118 |
Echinococcus multilocularis | twitchin | 0.0019 | 0.0009 | 0.0009 |
Schistosoma mansoni | Neurotrimin precursor (hNT) | 0.0049 | 0.0118 | 0.0118 |
Schistosoma mansoni | tyrosine kinase | 0.0258 | 0.0874 | 0.0874 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0061 | 0.0163 | 0.0163 |
Onchocerca volvulus | 0.0019 | 0.0009 | 0.0123 | |
Onchocerca volvulus | 0.0115 | 0.0357 | 0.5679 | |
Toxoplasma gondii | calcium dependent protein kinase CDPK8 | 0.002 | 0.0014 | 0.5 |
Schistosoma mansoni | kinase | 0.019 | 0.0627 | 0.0627 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0049 | 0.0118 | 0.0118 |
Loa Loa (eye worm) | hypothetical protein | 0.0106 | 0.0325 | 0.0325 |
Leishmania major | protein kinase, putative | 0.002 | 0.0014 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.0115 | 0.0357 | 0.0357 |
Brugia malayi | hypothetical protein | 0.0049 | 0.0118 | 0.0118 |
Loa Loa (eye worm) | CAMK/MLCK protein kinase | 0.0022 | 0.0023 | 0.0023 |
Schistosoma mansoni | protein kinase | 0.2784 | 1 | 1 |
Echinococcus granulosus | neurotracting:lsamp:neurotrimin:obcam | 0.0052 | 0.0131 | 0.0131 |
Trypanosoma cruzi | STE/STE11 serine/threonine-protein kinase, putative | 0.002 | 0.0014 | 0.5 |
Echinococcus granulosus | titin | 0.0019 | 0.0009 | 0.0009 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0118 | 0.0118 |
Schistosoma mansoni | cell adhesion molecule | 0.0052 | 0.0131 | 0.0131 |
Brugia malayi | Tyrosine-protein kinase abl-1 | 0.0111 | 0.0344 | 0.0344 |
Echinococcus granulosus | titin | 0.0019 | 0.0009 | 0.0009 |
Echinococcus granulosus | twitchin | 0.0067 | 0.0185 | 0.0185 |
Echinococcus granulosus | discoidin domain receptor | 0.0106 | 0.0325 | 0.0325 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0118 | 0.0118 |
Echinococcus granulosus | macrophage colony stimulating factor 1 receptor | 0.0676 | 0.2383 | 0.2383 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0019 | 0.0009 | 0.0009 |
Brugia malayi | Serine/threonine-protein kinase F42G10.2 | 0.019 | 0.0627 | 0.0627 |
Trypanosoma cruzi | STE/STE11 serine/threonine-protein kinase, putative | 0.002 | 0.0014 | 0.5 |
Echinococcus granulosus | activin receptor type | 0.002 | 0.0014 | 0.0014 |
Schistosoma mansoni | protein kinase | 0.002 | 0.0014 | 0.0014 |
Brugia malayi | Fibronectin type III domain containing protein | 0.0049 | 0.0118 | 0.0118 |
Echinococcus granulosus | tyrosine protein kinase Lyn | 0.0027 | 0.004 | 0.004 |
Trypanosoma brucei | protein kinase, putative | 0.002 | 0.0014 | 0.5 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0019 | 0.0009 | 0.0009 |
Echinococcus granulosus | roundabout 2 | 0.006 | 0.0159 | 0.0159 |
Loa Loa (eye worm) | hypothetical protein | 0.0102 | 0.0309 | 0.0309 |
Echinococcus granulosus | dual specificity mitogen activated protein | 0.019 | 0.0627 | 0.0627 |
Brugia malayi | protein unc-22 | 0.0019 | 0.0009 | 0.0009 |
Loa Loa (eye worm) | STE/STE7/MEK4 protein kinase | 0.019 | 0.0627 | 0.0627 |
Loa Loa (eye worm) | TK protein kinase | 0.0016 | 0.0002 | 0.0002 |
Echinococcus multilocularis | activin receptor type | 0.002 | 0.0014 | 0.0014 |
Schistosoma mansoni | nephrin | 0.0056 | 0.0146 | 0.0146 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0159 | 0.0159 |
Echinococcus multilocularis | titin | 0.0019 | 0.0009 | 0.0009 |
Plasmodium falciparum | protein kinase, putative | 0.002 | 0.0014 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0118 | 0.0118 |
Loa Loa (eye worm) | CAMK/MLCK protein kinase | 0.0019 | 0.0009 | 0.0009 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0118 | 0.0118 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | < 10 nM | Inhibition of human c-Kit V650G mutant using poly[Glu:Tyr] (4:1) peptide substrate | ChEMBL. | 23273517 |
IC50 (binding) | = 32.5 nM | Inhibition of human c-Kit using poly[Glu:Tyr] (4:1) peptide substrate | ChEMBL. | 23273517 |
IC50 (binding) | = 83.87 nM | Inhibition of human PDGFRalpha using poly[Glu:Tyr] (4:1) peptide substrate | ChEMBL. | 23273517 |
IC50 (binding) | > 200 nM | Inhibition of human c-Kit D816H mutant using poly[Glu:Tyr] (4:1) peptide substrate | ChEMBL. | 23273517 |
IC50 (binding) | = 653.3 nM | Inhibition of human DDR2 using KKSRGDYMTMQIG peptide substrate | ChEMBL. | 23273517 |
IC50 (binding) | = 973.9 nM | Inhibition of human FLT3 using EAIYAAPFAKKK peptide substrate | ChEMBL. | 23273517 |
IC50 (binding) | = 2953 nM | Inhibition of human ABL1 using EAIYAAPFAKKK peptide substrate | ChEMBL. | 23273517 |
IC50 (binding) | = 35400 nM | Inhibition of human PDGFRbeta using poly[Glu:Tyr] (4:1) peptide substrate | ChEMBL. | 23273517 |
IC50 (binding) | = 44620 nM | Inhibition of human LCK using poly[Glu:Tyr] (4:1) peptide substrate | ChEMBL. | 23273517 |
IC50 (binding) | = 45420 nM | Inhibition of human LYN using poly[Glu:Tyr] (4:1) peptide substrate | ChEMBL. | 23273517 |
IC50 (binding) | > 1 uM | Inhibition of human c-Kit V654A mutant using poly[Glu:Tyr] (4:1) peptide substrate | ChEMBL. | 23273517 |
IC50 (binding) | > 1 uM | Inhibition of human c-Kit T670I mutant using poly[Glu:Tyr] (4:1) peptide substrate | ChEMBL. | 23273517 |
IC50 (binding) | > 1 uM | Inhibition of human c-Kit D816V mutant using poly[Glu:Tyr] (4:1) peptide substrate | ChEMBL. | 23273517 |
Kd (binding) | = 4.4 nM | Binding affinity to human c-Kit | ChEMBL. | 23273517 |
Kd (binding) | = 7.2 nM | Binding affinity to human PDGFRbeata | ChEMBL. | 23273517 |
Kd (binding) | = 14 nM | Binding affinity to human PDGFRalpha | ChEMBL. | 23273517 |
Kd (binding) | = 29 nM | Binding affinity to human ABL1 | ChEMBL. | 23273517 |
Kd (binding) | = 320 nM | Binding affinity to human DDR2 | ChEMBL. | 23273517 |
Kd (binding) | = 1400 nM | Binding affinity to human FLT3 | ChEMBL. | 23273517 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.